319 related articles for article (PubMed ID: 9774227)
1. Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vitro: synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2.
Seidel MG; Freissmuth M; Pehamberger H; Micksche M
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):382-9. PubMed ID: 9774227
[TBL] [Abstract][Full Text] [Related]
2. Differential quantitative effects of interleukin (IL)-2 and IL-15 on cytotoxic activity and proliferation by lymphocytes from patients receiving in vivo IL-2 therapy.
de Jong JL; Farner NL; Javorsky BR; Lindstrom MJ; Hank JA; Sondel PM
Clin Cancer Res; 1998 May; 4(5):1287-96. PubMed ID: 9607589
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism.
Gamero AM; Ussery D; Reintgen DS; Puleo CA; Djeu JY
Cancer Res; 1995 Nov; 55(21):4988-94. PubMed ID: 7585540
[TBL] [Abstract][Full Text] [Related]
4. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients.
Chen YM; Yang WK; Ting CC; Tsai WY; Yang DM; Whang-Peng J; Perng RP
Chest; 1997 Oct; 112(4):960-6. PubMed ID: 9377959
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15.
Vuletić AM; Jovanić IP; Jurišić VB; Milovanović ZM; Nikolić SS; Tanić NT; Konjević GM
Melanoma Res; 2015 Feb; 25(1):22-34. PubMed ID: 25380182
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of cytokine-induced proliferation of human Natural Killer cells by intravenous immunoglobulin G.
Issekutz AC; Derfalvi B; Käsermann F; Rowter D
Clin Immunol; 2015 Dec; 161(2):373-83. PubMed ID: 26307433
[TBL] [Abstract][Full Text] [Related]
7. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
[TBL] [Abstract][Full Text] [Related]
8. Induction by interleukin-15 of human killer cell activity against lung cancer cell lines and its regulatory mechanisms.
Takeuchi E; Yanagawa H; Yano S; Haku T; Sone S
Jpn J Cancer Res; 1996 Dec; 87(12):1251-8. PubMed ID: 9045960
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.
Ferreira-Teixeira M; Paiva-Oliveira D; Parada B; Alves V; Sousa V; Chijioke O; Münz C; Reis F; Rodrigues-Santos P; Gomes C
BMC Med; 2016 Oct; 14(1):163. PubMed ID: 27769244
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell stimulatory factor (NKSF)/IL-12 and cytolytic activities of PBL/NK cells from human immunodeficiency virus type-1 infected patients.
Sirianni MC; Ansotegui IJ; Aiuti F; Wigzell H
Scand J Immunol; 1994 Jul; 40(1):83-6. PubMed ID: 7913248
[TBL] [Abstract][Full Text] [Related]
11. The regulation and biological activity of interleukin 12.
Lee SM; Suen Y; Qian J; Knoppel E; Cairo MS
Leuk Lymphoma; 1998 May; 29(5-6):427-38. PubMed ID: 9643557
[TBL] [Abstract][Full Text] [Related]
12. Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction.
Konjević G; Mirjačić Martinović K; Vuletić A; Radenković S
Biomed Pharmacother; 2010 Dec; 64(10):663-71. PubMed ID: 20800424
[TBL] [Abstract][Full Text] [Related]
13. Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients.
Mirjačić Martinović K; Babović N; Džodić R; Jurišić V; Matković S; Konjević G
J Transl Med; 2015 Apr; 13():120. PubMed ID: 25889680
[TBL] [Abstract][Full Text] [Related]
14. Impaired STAT phosphorylation in T cells from melanoma patients in response to IL-2: association with clinical stage.
Mortarini R; Vegetti C; Molla A; Arienti F; Ravagnani F; Maurichi A; Patuzzo R; Santinami M; Anichini A
Clin Cancer Res; 2009 Jun; 15(12):4085-94. PubMed ID: 19509154
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cytotoxic function and apoptosis in interleukin (IL)-12/IL-15-treated umbilical cord or adult peripheral blood natural killer cells by a propidium-iodide based flow cytometry.
Lin SJ; Cheng PJ; Huang YJ; Kuo ML
Pediatr Allergy Immunol; 2004 Feb; 15(1):79-85. PubMed ID: 14998386
[TBL] [Abstract][Full Text] [Related]
16. Activation of porcine natural killer cells and lysis of foot-and-mouth disease virus infected cells.
Toka FN; Nfon CK; Dawson H; Estes DM; Golde WT
J Interferon Cytokine Res; 2009 Mar; 29(3):179-92. PubMed ID: 19196070
[TBL] [Abstract][Full Text] [Related]
17. Interleukins 2 and 12 activate natural killer cytolytic responses of peripheral blood mononuclear cells from patients with head and neck squamous cell carcinoma.
Rashleigh SP; Kusher DI; Endicott JN; Rossi AR; Djeu JY
Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):541-7. PubMed ID: 8615973
[TBL] [Abstract][Full Text] [Related]
18. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.
Chehimi J; Starr SE; Frank I; Rengaraju M; Jackson SJ; Llanes C; Kobayashi M; Perussia B; Young D; Nickbarg E
J Exp Med; 1992 Mar; 175(3):789-96. PubMed ID: 1346797
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12 induces efficient lysis of natural killer-sensitive and natural killer-resistant human osteosarcoma cells: the synergistic effect of interleukin-2.
Mariani E; Meneghetti A; Tarozzi A; Cattini L; Facchini A
Scand J Immunol; 2000 Jun; 51(6):618-25. PubMed ID: 10849374
[TBL] [Abstract][Full Text] [Related]
20. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
Lauwerys BR; Renauld JC; Houssiau FA
Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
